We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
101
Frontier Capital Management
Massachusetts
– -$5.44M -100,878 Closed
HSBC Holdings
102
HSBC Holdings
United Kingdom
– -$5.34M -99,003 Closed
State of Tennessee, Department of Treasury
103
State of Tennessee, Department of Treasury
Tennessee
– -$4.85M -90,000 Closed
Canada Life
104
Canada Life
Manitoba, Canada
– -$4.74M -87,893 Closed
Ohio Public Employees Retirement System (OPERS)
105
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$4.72M -87,619 Closed
MOACM
106
Mutual of America Capital Management
New York
– -$4.71M -87,259 Closed
Comerica Bank
107
Comerica Bank
Texas
– -$8.83M -85,357 Closed
UBS Group
108
UBS Group
Switzerland
– -$4.47M -82,933 Closed
ASRS
109
Arizona State Retirement System
Arizona
– -$4.2M -77,851 Closed
AllianceBernstein
110
AllianceBernstein
Tennessee
– -$4.03M -74,666 Closed
TPSF
111
Texas Permanent School Fund
Texas
– -$3.94M -73,112 Closed
Federated Hermes
112
Federated Hermes
Pennsylvania
– -$3.86M -71,587 Closed
ProShare Advisors
113
ProShare Advisors
Maryland
– -$3.8M -70,550 Closed
MIM
114
MetLife Investment Management
New Jersey
– -$3.69M -68,434 Closed
GCP
115
GSA Capital Partners
United Kingdom
– -$3.47M -64,314 Closed
OA
116
Outfitter Advisors
Virginia
– -$3.39M -62,872 Closed
Aviva
117
Aviva
United Kingdom
– -$3.31M -61,388 Closed
PI
118
PineBridge Investments
New York
– -$3.09M -57,300 Closed
MSA
119
Mason Street Advisors
Wisconsin
– -$2.87M -53,287 Closed
Harris Associates
120
Harris Associates
Illinois
– -$2.87M -53,255 Closed
Invesco
121
Invesco
Georgia
– -$2.81M -52,100 Closed
PA
122
Profund Advisors
Maryland
– -$2.76M -51,133 Closed
Nisa Investment Advisors
123
Nisa Investment Advisors
Missouri
– -$2.74M -50,843 Closed
DZ Bank
124
DZ Bank
Germany
– -$2.73M -50,640 Closed
PAMU
125
Pictet Asset Management (UK)
United Kingdom
– -$2.63M -48,824 Closed
3 4
5
6 7

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.